tradingkey.logo
tradingkey.logo
Search

CytomX Therapeutics Inc

CTMX
Add to Watchlist
3.220USD
+0.120+3.87%
Close 07-31 16:00ETQuotes delayed by 15 min
548.00MMarket Cap
LossP/E TTM

CTMX Financials

See CytomX Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

CytomX Therapeutics Inc Earnings Date

Latest Release
Aug 6, 2026
EPS / Forecast
--/-0.08
Revenue / Forecast
--/12.31M
Period
FY2025 Earnings
Revenue(YoY)
76.20M
-44.82%
EPS(YoY)
-0.15
-139.13%
Analyst Rating
STRONG BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-138.12%-0.10
-179.00%-0.17
-227.92%-0.09
98.45%0.00
60.62%0.27
2045.71%0.22
81.89%0.07
-371.11%-0.08
436.37%0.17
102.43%0.01
--0.04
---0.02
---0.05
---0.42
---1.38
----
----
----
----
----
Revenue
-79.85%10.26M
-98.26%663.00K
-82.16%5.96M
-25.71%18.66M
22.80%50.92M
43.17%38.09M
26.71%33.43M
1.58%25.11M
76.45%41.46M
2712.58%26.61M
136.69%26.38M
92.36%24.72M
159.94%23.50M
107.55%946.00K
-36.62%11.15M
-21.09%12.85M
-43.40%9.04M
-176.55%-12.53M
-1.13%17.59M
-1.93%16.29M
Net Profit
-177.57%-18.25M
-256.35%-29.51M
-348.06%-14.23M
97.64%-154.00K
70.58%23.52M
2155.20%18.88M
91.71%5.74M
-501.10%-6.53M
516.52%13.79M
102.99%837.00K
110.29%2.99M
96.31%-1.09M
89.65%-3.31M
52.21%-27.95M
-28.69%-29.06M
-53.28%-29.50M
-105.61%-31.98M
-297.86%-58.49M
-53.53%-22.58M
-22.73%-19.24M
Net Margin
-485.02%-177.89%
-8169.22%-3998.49%
-1490.79%-238.62%
96.83%-0.83%
38.91%46.20%
1475.20%49.55%
51.30%17.16%
-491.75%-26.02%
336.06%33.26%
100.11%3.15%
--11.34%
---4.40%
---14.09%
---2954.76%
---274.04%
----
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
Revenue
-79.85%10.26M
-98.26%663.00K
-82.16%5.96M
-25.71%18.66M
22.80%50.92M
43.17%38.09M
26.71%33.43M
1.58%25.11M
76.45%41.46M
2712.58%26.61M
136.69%26.38M
92.36%24.72M
159.94%23.50M
107.55%946.00K
-36.62%11.15M
-21.09%12.85M
-43.40%9.04M
-176.55%-12.53M
-1.13%17.59M
-1.93%16.29M
Operating profit
-186.96%-19.67M
-258.00%-27.93M
-483.56%-15.77M
84.78%-1.29M
94.06%22.62M
3017.33%17.68M
32.91%4.11M
-148.52%-8.45M
309.28%11.66M
97.89%-606.00K
110.41%3.09M
88.68%-3.40M
82.63%-5.57M
51.02%-28.68M
-31.22%-29.71M
-56.49%-30.05M
-105.17%-32.06M
-296.30%-58.57M
-52.00%-22.64M
-19.00%-19.20M
Net Profit
-177.57%-18.25M
-256.35%-29.51M
-348.06%-14.23M
97.64%-154.00K
70.58%23.52M
2155.20%18.88M
91.71%5.74M
-501.10%-6.53M
516.52%13.79M
102.99%837.00K
110.29%2.99M
96.31%-1.09M
89.65%-3.31M
52.21%-27.95M
-28.69%-29.06M
-53.28%-29.50M
-105.61%-31.98M
-297.86%-58.49M
-53.53%-22.58M
-22.73%-19.24M
Current assets
307.60%353.10M
34.12%143.92M
20.16%149.22M
15.06%164.62M
-48.20%86.63M
-41.34%107.31M
-38.28%124.18M
-23.81%143.08M
-21.21%167.25M
-22.85%182.94M
0.46%201.20M
-19.32%187.80M
-20.92%212.28M
-23.59%237.10M
-16.90%200.28M
-14.11%232.77M
-32.89%268.44M
-4.23%310.30M
-29.18%241.00M
-26.07%271.00M
Total current liabilities
-32.23%34.02M
-45.65%46.62M
-65.59%41.03M
-72.54%39.22M
-65.27%50.20M
-44.99%85.77M
-18.78%119.23M
1.05%142.86M
-4.45%144.54M
2.17%155.91M
50.03%146.79M
42.17%141.38M
47.19%151.26M
95.98%152.61M
-1.94%97.84M
6.49%99.44M
4.81%102.77M
-22.84%77.87M
-2.22%99.77M
-5.47%93.38M
Total assets
264.84%359.36M
25.75%151.57M
13.87%158.25M
9.95%175.06M
-46.67%98.50M
-40.27%120.53M
-37.16%138.98M
-23.89%159.22M
-21.29%184.69M
-22.65%201.79M
-2.35%221.17M
-19.57%209.19M
-20.95%234.63M
-23.13%260.89M
-38.99%226.49M
-35.37%260.09M
-31.63%296.82M
-5.37%339.41M
-1.05%371.23M
-0.01%402.44M
Total liabilities
-46.34%39.41M
-56.56%52.56M
-68.69%50.87M
-71.04%55.15M
-66.05%73.45M
-51.46%120.99M
-40.37%162.43M
-35.27%190.45M
-32.65%216.37M
-28.10%249.24M
37.57%272.40M
39.19%294.21M
40.52%321.27M
1.99%346.64M
-23.71%198.02M
-22.14%211.38M
-20.65%228.63M
10.04%339.87M
-20.65%259.56M
-21.00%271.49M
Total equity
1177.27%319.94M
21812.28%99.01M
557.91%107.39M
483.99%119.91M
179.07%25.05M
99.04%-456.00K
54.23%-23.45M
63.27%-31.23M
63.43%-31.68M
44.67%-47.45M
-279.95%-51.24M
-274.56%-85.03M
-227.04%-86.64M
-18582.14%-85.75M
-74.50%28.47M
-62.80%48.71M
-53.30%68.19M
-100.92%-459.00K
132.34%111.67M
122.60%130.95M
Net operating income
-21.41%-25.55M
-16.75%-23.24M
24.99%-15.55M
19.42%-15.75M
19.21%-21.04M
9.36%-19.91M
-13.63%-20.73M
22.36%-19.55M
-378.59%-26.05M
-1475.54%-21.96M
46.10%-18.24M
26.46%-25.18M
122.63%9.35M
95.53%-1.39M
-13.95%-33.84M
-21.41%-34.24M
-37.99%-41.31M
-78.99%-31.19M
-20.35%-29.70M
-129.04%-28.20M
Net investment
-730.07%-192.78M
-195.27%-14.42M
-97.58%439.00K
-454.96%-76.36M
-31.83%30.60M
17.64%15.13M
142.31%18.17M
-17.39%21.51M
130.61%44.88M
-87.11%12.87M
-10372.68%-42.94M
6420.39%26.04M
-19824.18%-146.64M
40842.04%99.82M
-104.21%-410.00K
99.10%-412.00K
-101.25%-736.00K
-101.26%-245.00K
110.81%9.73M
-193.04%-46.01M
Net financing
--234.49M
640.02%16.64M
--253.00K
1734.67%93.55M
-100.00%0.00
821.72%2.25M
-100.00%0.00
1508.52%5.10M
--174.00K
28.42%244.00K
--29.67M
-29.71%317.00K
-100.00%0.00
-72.18%190.00K
-100.00%0.00
-34.73%451.00K
-99.99%7.00K
-94.75%683.00K
-37.72%104.00K
-55.36%691.00K

FAQs

What is the total revenue of CytomX Therapeutics Inc?

According to CytomX Therapeutics Inc's FY2025 earnings report, its total revenue reached 76.20M, with a year-on-year change of 138.10M.

What are the current assets of CytomX Therapeutics Inc?

According to CytomX Therapeutics Inc's FY2025 earnings report, its current assets were 143.92M, with a year-on-year change of 34.12.

What are the total assets of CytomX Therapeutics Inc?

According to CytomX Therapeutics Inc's FY2025 earnings report, its total assets of CytomX Therapeutics Inc were 151.57M, with a year-on-year change of 25.75.

What are the total liabilities of CytomX Therapeutics Inc?

According to CytomX Therapeutics Inc's FY2025 earnings report, its total liabilities of CytomX Therapeutics Inc were 52.56M, with a year-on-year change of -56.56.

What is the total equity of CytomX Therapeutics Inc?

According to CytomX Therapeutics Inc's FY2025 earnings report, its total equity of CytomX Therapeutics Inc was 99.01M, with a year-on-year change of 21812.28.

What is the net operating income of CytomX Therapeutics Inc?

According to CytomX Therapeutics Inc's FY2025 earnings report, its net operating income of CytomX Therapeutics Inc was -19.16M, with a year-on-year change of -176.67.

What is the net investment of CytomX Therapeutics Inc?

According to CytomX Therapeutics Inc's FY2025 earnings report, its net investment of CytomX Therapeutics Inc was -59.74M, with a year-on-year change of -159.92.

What is the net financing of CytomX Therapeutics Inc?

According to CytomX Therapeutics Inc's FY2025 earnings report, its net financing of CytomX Therapeutics Inc was 110.45M, with a year-on-year change of 1368.31.

What is the Earnings Per Share (EPS) of CytomX Therapeutics Inc?

According to CytomX Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.15, with a year-on-year change of -139.13.

What is the net income of CytomX Therapeutics Inc?

According to CytomX Therapeutics Inc's FY2025 earnings report, its net income was -20.37M, with a year-on-year change of -163.92.

What is the net margin of CytomX Therapeutics Inc?

According to CytomX Therapeutics Inc's FY2025 earnings report, its net profit margin was -22.79, with a year-on-year change of -198.77.

What is the Return on Assets (ROA) of CytomX Therapeutics Inc?

According to CytomX Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -12.77, with a year-on-year change of -164.56.

What is the operating profit of CytomX Therapeutics Inc?

According to CytomX Therapeutics Inc's FY2025 earnings report, its operating profit was -19.16M, with a year-on-year change of -176.67.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.